It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ytterbium-175 (175Yb) is considered suitable for the preparation of therapeutic radiopharmaceuticals due to its decay characteristics (T1/2 = 4.18 d). In this study, the reaction cross section via the (n, p) reaction for 175Yb was theoretically calculated using Lutetium-175 (175Lu) as the target material. Neutrons with energies up to 50 MeV were considered, taking into account all nuclear reaction mechanisms. The Q-value for the neutron-induced reaction is 312 keV. The produced 175Yb can be converted back to the parent stable nuclei 175Lu through beta decay (100%), with no co -produced impurities remaining during the production of 175Yb. This makes it suitable for the preparation of potential radiotherapeutic and imaging agents. The deterministic codes EMPIRE -3.2.3 and TALYS-2.0 were used in this study with their default models as well as optimized models. Experimental data were also included for comparison from the EXFOR data library. Major newly evaluated nuclear data libraries such as ENDF, JEFF, and TENDL were used for comparison. The results were found to be comparable with some discrepancies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer